Viridian Therapeutics, Inc. VRDN Earnings yield
Earnings yield at other companies
Other financials
Where this comes from
Calculated from Viridian Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Viridian Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Viridian Therapeutics, Inc.'s earnings yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Viridian Therapeutics, Inc.'s earnings yield?
- Viridian Therapeutics, Inc. (VRDN) reported earnings yield of -18% in Q1 2026.
- How has Viridian Therapeutics, Inc.'s earnings yield changed year-over-year?
- Viridian Therapeutics, Inc.'s earnings yield increased by 35.7% year-over-year, from -28.1% to -18%.
- What is the long-term trend for Viridian Therapeutics, Inc.'s earnings yield?
- Over 5 years (2020 to 2025), Viridian Therapeutics, Inc.'s earnings yield has grown at a -35.9% compound annual growth rate (CAGR), from -106.2% to -11.5%.
- What does earnings yield mean?
- Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.